Newsletter

Some of the subjects covered in the past issues of the Newsletter:

Acomplia

Acomplia (with Rimonabant) is a weight loss aid that has recently been approved in the U.K., making it the first selective CB1 receptor blocker to be approved in the world. It is designed for treatment of obese and overweight patients, especially those with other risk factors, such as dyslipidaemia or type 2 diabetes. Acomplia is known under the brand name Zimulti in U.S...

Can-C

Can-C is a non-invasive, anti-oxidant eye drop - the only cataract eye drop proven in clinical trials to be effective in the treatment of cataracts and safe for long-term use. Approved and patented by Innovative Vision Products, who developed the technology behind this breakthrough in cataract treatment, Can-C contains N-acetylcarnosine a natural and powerful anti-oxidant...

Deprenyl Jumex

Discovered in 1961 by Hungarian Professor Dr Joseph Knoll in his Budapest laboratory, Deprenyl is the only potent, selective, irreversible MAO-B inhibitor approved for medical use. MAO-B causes the breakdown of dopamine (a monoamine) into chemical compounds which are then excreted by the body. Jumex works by helping to prevent (or inhibit) this breakdown of dopamine by MAO-B. Dopamine is essential to the normal functioning of the central nervous system. It also plays a significant role in the cardiovascular, renal and hormonal systems of the body...

Desmopressin

Desmopressin is a man-made form of vasopressin, a hormone that occurs naturally in the brain of most mammals including humans. The primary function of vasopressin is to regulate the body’s retention of water which also affects the amount of salt in your body...

Olmifon

Olmifon is brand name for Adrafinil - a gentle stimulant and an anti-depressant, used to boost vigilance and alertness. It has the ability to stimulate only when stimulation is required and has far fewer of the anxiety, agitation and insomnia inducing side effects of the more well known stimulants...

Piracetam

Piracetam was developed in the 1960s by a Belgian team led by Dr Corneliu Giurgea. It was Dr Corneliu who coined the word ‘nootropic’ – taken from the Greek word meaning ‘acting on or towards the mind’. Piracetam itself has been described as a drug that “wakes up your brain”...